Trial intelligence / Profile preview

Stone Size Stratified Effect of Adjuvant Silodosin on Stone Clearance After ESWL for Renal Stones

TCTR20260212007Phase 4Completed

Sponsor
Rayong Hospital
Start
Apr 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of silodosin in nephrolithiasis, sponsored by Rayong Hospital. Started Apr 2023; status: completed.

02

Drugs

silodosin
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on TCTR20260212007.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260212007.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call